KDIGO 2024 clinical practice guideline for CKD

Plain-language summary

The updated CKD evaluation-and-management guideline, including validated GFR-estimating equations for drug dosing and incorporation of cystatin C when creatinine-based eGFR is unreliable.

Key findings

• Recommends cystatin C to confirm eGFR in specific situations and for drug-dosing decisions.
• Broad update to CKD evaluation, risk assessment, and management.

Population

Adults and children with CKD.

Primary source

KDIGO 2024 CKD Guideline. Kidney Int. 2024;105(4S):S117–S314.
https://doi.org/10.1016/j.kint.2023.10.018